Business Description
MaxCyte Inc
NAICS : 334510
SIC : 3845
ISIN : US57777K1060
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 8.45 | |||||
Equity-to-Asset | 0.88 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | -0.43 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 9 | |||||
Beneish M-Score | 46.89 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.1 | |||||
3-Year EBITDA Growth Rate | -47.2 | |||||
3-Year EPS without NRI Growth Rate | -32.3 | |||||
3-Year FCF Growth Rate | -18.7 | |||||
3-Year Book Growth Rate | 60 | |||||
Future 3-5Y Total Revenue Growth Rate | 17.59 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 78.79 | |||||
9-Day RSI | 74.49 | |||||
14-Day RSI | 68.14 | |||||
6-1 Month Momentum % | 12.1 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 13.26 | |||||
Quick Ratio | 12.37 | |||||
Cash Ratio | 11.69 | |||||
Days Inventory | 830.37 | |||||
Days Sales Outstanding | 61.78 | |||||
Days Payable | 114.94 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -21.9 | |||||
Shareholder Yield % | -0.23 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 88.33 | |||||
Operating Margin % | -107.88 | |||||
Net Margin % | -83.26 | |||||
FCF Margin % | -70.33 | |||||
ROE % | -15.39 | |||||
ROA % | -13.5 | |||||
ROIC % | -69.5 | |||||
ROC (Joel Greenblatt) % | -114.53 | |||||
ROCE % | -18.57 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 11.22 | |||||
PB Ratio | 2.22 | |||||
Price-to-Tangible-Book | 2.18 | |||||
EV-to-EBIT | -7.33 | |||||
EV-to-EBITDA | -8.07 | |||||
EV-to-Forward-EBITDA | -10.6 | |||||
EV-to-Revenue | 7.92 | |||||
EV-to-Forward-Revenue | 5.6 | |||||
EV-to-FCF | -11.6 | |||||
Price-to-Projected-FCF | 9.63 | |||||
Price-to-Net-Current-Asset-Value | 3.37 | |||||
Price-to-Net-Cash | 3.91 | |||||
Earnings Yield (Greenblatt) % | -13.64 | |||||
FCF Yield % | -6.34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
MaxCyte Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 40.648 | ||
EPS (TTM) (€) | -0.324 | ||
Beta | 0 | ||
Volatility % | 72.28 | ||
14-Day RSI | 68.14 | ||
14-Day ATR (€) | 0.182279 | ||
20-Day SMA (€) | 3.561 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (€) | 1.1 - 4.74 | ||
Shares Outstanding (Mil) | 104.54 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
MaxCyte Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
MaxCyte Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
MaxCyte Inc Frequently Asked Questions
What is MaxCyte Inc(STU:MYE0)'s stock price today?
When is next earnings date of MaxCyte Inc(STU:MYE0)?
Does MaxCyte Inc(STU:MYE0) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |